RenovoRx, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
RenovoRx, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
  • RenovoRx, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 87.2 %, a 16.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 87.2 -16.9 -16.2% Sep 30, 2024
Q2 2024 171 +125 +271% Jun 30, 2024
Q1 2024 -41.3K -41.4K -247255% Mar 31, 2024
Q4 2023 994 +981 +7663% Dec 31, 2023
Q3 2023 104 +94.2 +951% Sep 30, 2023
Q2 2023 46 +38.7 +525% Jun 30, 2023
Q1 2023 16.7 Mar 31, 2023
Q4 2022 12.8 Dec 31, 2022
Q3 2022 9.9 Sep 30, 2022
Q2 2022 7.36 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.